Organon & Co. (OGN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EST
After hours:
| Previous close | 32.24 |
| Open | 32.21 |
| Bid | 31.49 x 1200 |
| Ask | 31.84 x 1200 |
| Day's range | 31.78 - 32.71 |
| 52-week range | 27.25 - 38.75 |
| Volume | |
| Avg. volume | 2,083,677 |
| Market cap | 8.068B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 5.33 |
| EPS (TTM) | 5.97 |
| Earnings date | 11 Nov 2021 |
| Forward dividend & yield | 1.12 (3.47%) |
| Ex-dividend date | 19 Nov 2021 |
| 1y target est | 39.57 |
- Business Wire
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
INCHEON, Korea & JERSEY CITY, N.J., January 05, 2022--FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
- Business Wire
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
JERSEY CITY, N.J., December 20, 2021--Organon CEO and CFO to participate in JP Morgan Conference Fireside Chat
- Business Wire
Organon Completes Acquisition of Forendo Pharma
JERSEY CITY, N.J., December 13, 2021--Organon Announces Close of Forendo Pharma
© 2022 Yahoo. All rights reserved.
